Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with obstructive sleep apnea (OSA):
- Adults between 18 and 65 years of age
- People with moderate or severe sleep apnea, confirmed by an overnight sleep study showing 15 or more breathing interruptions per hour
- People who are willing and able to sign a consent form agreeing to take part
- People who are willing to have blood samples taken at multiple points during the study
- People who are willing to use a breathing device (such as a CPAP machine) and accept being randomly assigned to start treatment either straight away or after a delay
For people joining as healthy comparison participants (controls):
- Adults between 18 and 65 years of age
- People with no sleep apnea, confirmed by an overnight sleep study showing fewer than 5 breathing interruptions per hour
- People who are willing and able to sign a consent form agreeing to take part
- People who are willing to have blood samples taken and complete study assessments
Who may not be able to join:
- People with mild sleep apnea (between 5 and fewer than 15 breathing interruptions per hour on a sleep study)
- People whose breathing interruptions during sleep originate from the brain rather than a physical airway blockage (known as central sleep apnea)
- People who have received treatment for sleep apnea in the past 3 months
- People with a body mass index (BMI) of 40 or above (a measure of body weight relative to height)
- People with serious heart or blood vessel disease
- People with serious kidney disease or significantly reduced kidney function
- People with significant liver disease
- People with ongoing conditions affecting the immune system, such as autoimmune or rheumatic diseases, or other long-term inflammatory conditions
- People with active cancer or any other condition known to cause widespread inflammation in the body
- People with long-term lung or breathing conditions, such as asthma or chronic obstructive pulmonary disease (COPD)
- People who have had a respiratory infection (such as a cold or chest infection) within the 4 weeks before enrolling
- People who have had major surgery or a significant injury within the past 3 months
- People with a long-term condition causing blocked or inflamed sinuses (chronic rhinosinusitis)
- People currently taking steroid tablets, medicines that suppress the immune system, chemotherapy-type drugs, long-term anti-inflammatory medications, or other medicines that may affect inflammation markers in the blood
- People who are pregnant, or who have any other condition that the trial doctors consider would make participation unsafe or affect the study results (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +48 85 831 82 69
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in blood biomarker concentrations between participants with obstructive sleep apnea (OSA) and non-OSA controls at baseline; Change in blood biomarker concentrations in OSA participants after positive airway pressure (PAP) therapy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.